Abstract
Dear Editor, Ticagrelor is a recently introduced antiplatelet drug that has shown superiority over clopidogrel in reducing overall mortality in acute coronary syndrome (ACS). The drug is an ADP P2Y12...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
